Investing Profile

Andrew Hack

InvestorVC
Managing Director at Bain Capital Life Sciences
baincapital.comBoston, Massachusetts
Photo of Andrew Hack, Managing Director at Bain Capital Life Sciences
cb
Bain Capital Life Sciences Managing Director
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
JenaValve Technology
Series CAug 2022$100M
Series UnknownFeb 2020$50M
$270M
Co-investors: Olivier Litzka (Andera Partners), Peter Barrett (Atlas Venture)
Nuvalent
Series BMay 2021$140M
$190M
Co-investors: Cameron Wheeler (Deerfield Management)
Xilio Therapeutics
Series CFeb 2021$95M
$330M
Co-investors: Peter Dudek (MRL Ventures Fund), Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Nancy Hong (RiverVest), Jack Kenney (SV Health Investors)
Affinivax
Series CJan 2021$230M
Series BApr 2020$120M
$350M
Co-investors: Dorothy Margolskee (Foresite Capital)
Atea Pharmaceuticals
Series DMay 2020$220M
$220M